These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2508416)

  • 21. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure.
    Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD
    Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity.
    Besinger UA; Toyka KV; Hömberg M; Heininger K; Hohlfeld R; Fateh-Moghadam A
    Neurology; 1983 Oct; 33(10):1316-21. PubMed ID: 6684226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J
    Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
    Maruyama N; Shigemoto K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial autoimmune myasthenia gravis with different pathogenetic antibodies.
    Provenzano C; Arancio O; Evoli A; Rocca B; Bartoccioni E; de Grandis D; Tonali P
    J Neurol Neurosurg Psychiatry; 1988 Sep; 51(9):1228-30. PubMed ID: 3225607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies.
    Finsterer J
    Scand J Infect Dis; 2007; 39(2):187-90. PubMed ID: 17366045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
    Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
    Nature; 1983 Feb 17-23; 301(5901):611-4. PubMed ID: 6402708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modulation of experimental myasthenia gravis by IVIg].
    Berrih-Aknin S; Aissaoui A; Yamamoto M; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S25-9. PubMed ID: 10896985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis.
    Plomp JJ; Huijbers MG; van der Maarel SM; Verschuuren JJ
    Ann N Y Acad Sci; 2012 Dec; 1275():114-22. PubMed ID: 23278586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiotypes and anti-idiotypes of human autoantibodies to the acetylcholine receptor in myasthenia gravis.
    Lefvert AK
    Monogr Allergy; 1987; 22():57-70. PubMed ID: 3325836
    [No Abstract]   [Full Text] [Related]  

  • 36. Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis.
    Heilbronn E; Lefvert AK; Stålberg E
    Muscle Nerve; 1978; 1(5):427-31. PubMed ID: 263985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunopathology of myasthenia gravis.
    Drachman DB
    Fed Proc; 1979 Nov; 38(12):2613-5. PubMed ID: 227751
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of myasthenic immunoglobulins on neuromuscular transmission and thymus histology in mice.
    Dalkara T; Onur R; Ruacan SA; Topaktaş S
    Neurology; 1983 Oct; 33(10):1356-9. PubMed ID: 6310440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
    Ohta R; Motomura M
    Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.